Retrospective Analysis for Femoropopliteal Stenting of 1000 limbs

Retrospective Analysis for Femoropopliteal Stenting of 1000 limbs - REAL-FP1000

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000004425

Enrollment

800

Registered

2010-10-21

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoroppliteal disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who underwent successful EVT with a nitinol stent for de novo lesions

Exclusion criteria

Exclusion criteria: balloon angioplasty alone, restenotic lesions, use of a metallic stent, acute or subacute limb ischemia or history of lower extremities bypass surgery or endovascular treatment

Design outcomes

Primary

Measure	Time frame
primary patency (incidence of in-stent restenosis)in patients with and without cilostazol, chronic total occlusion or hemodialysis. Angiographic patterns of in-stent restenosis	—

Secondary

Measure	Time frame
Secondary patency (re-occlusion rate)	—

Countries

Japan

Outcome results